Cyteir Therapeutics, Inc.·4

Feb 7, 4:14 PM ET

Veness Adam M 4

4 · Cyteir Therapeutics, Inc. · Filed Feb 7, 2023

Insider Transaction Report

Form 4
Period: 2023-02-03
Veness Adam M
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-03+96,10096,100 total
    Exercise: $1.69Exp: 2033-02-03Common Stock (96,100 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments after the grant date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION